Header Logo

Connection

DAVID POPLACK to Injections, Intravenous

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Injections, Intravenous.
DAVID POPLACK
Connection Strength
0.331
Injections, Intravenous
  1. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res. 1993 Feb 01; 53(3):472-6.
    View in: PubMed
    Score: 0.026
  2. Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 02; 84(17):1332-5.
    View in: PubMed
    Score: 0.025
  3. Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9.
    View in: PubMed
    Score: 0.022
  4. Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys. Antimicrob Agents Chemother. 1989 Jun; 33(6):810-2.
    View in: PubMed
    Score: 0.020
  5. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
    View in: PubMed
    Score: 0.017
  6. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res. 1986 Dec; 46(12 Pt 1):6101-4.
    View in: PubMed
    Score: 0.017
  7. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun; 12(2):131-48.
    View in: PubMed
    Score: 0.015
  8. Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Deliv. 1985; 2(4):247-53.
    View in: PubMed
    Score: 0.015
  9. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984 Nov; 44(11):4929-32.
    View in: PubMed
    Score: 0.015
  10. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
    View in: PubMed
    Score: 0.014
  11. Intrathecally administered m-AMSA in the rhesus monkey. Cancer Drug Deliv. 1984; 1(2):101-7.
    View in: PubMed
    Score: 0.014
  12. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther. 1983 Dec; 34(6):810-7.
    View in: PubMed
    Score: 0.014
  13. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9.
    View in: PubMed
    Score: 0.013
  14. Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus. Drug Metab Dispos. 1983 Jan-Feb; 11(1):5-9.
    View in: PubMed
    Score: 0.013
  15. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1982 May; 42(5):1736-9.
    View in: PubMed
    Score: 0.012
  16. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. J Natl Cancer Inst. 1982 Mar; 68(3):391-3.
    View in: PubMed
    Score: 0.012
  17. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
    View in: PubMed
    Score: 0.012
  18. Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol. 1981; 5(4):257-60.
    View in: PubMed
    Score: 0.011
  19. Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
    View in: PubMed
    Score: 0.010
  20. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
    View in: PubMed
    Score: 0.008
  21. Candida arthritis treated with amphotericin B. J Pediatr. 1975 Dec; 87(6 Pt 1):989-90.
    View in: PubMed
    Score: 0.008
  22. High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. J Chromatogr. 1990 Mar 16; 526(1):69-75.
    View in: PubMed
    Score: 0.005
  23. Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6.
    View in: PubMed
    Score: 0.005
  24. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos. 1987 Sep-Oct; 15(5):595-601.
    View in: PubMed
    Score: 0.004
  25. Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration. Eur J Cancer (1965). 1981 Jan; 17(1):29-34.
    View in: PubMed
    Score: 0.003
  26. Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol. 1979; 1(2):127-40.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.